How Stem Cell Transplant and CAR-T Affect Life
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study asks patients with blood cancers to share their experiences and well-being after a donor stem cell transplant or CAR-T treatment. It uses simple questionnaires to learn how these treatments affect daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer such as leukemia, lymphoma, or multiple myeloma
- You are receiving or have received a donor stem cell transplant or CAR-T therapy
- You can understand Italian and fill out a health questionnaire
- You are able to give your consent to join the study
- You do not have severe memory or thinking problems that would prevent you from completing surveys
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the rehabilitation needs of people with blood cancers who are about to have a stem cell transplant or CAR T-cell therapy. It aims to understand what kind of support patients need to stay active and recover better.
This study looks at how patients with blood cancers are managed in real life when they receive CAR-T cell therapy. It helps doctors learn more about how well these treatments work outside of clinical trials.
This study looks at tissue samples from adults who are receiving CAR-T cell therapy for blood-related conditions. It aims to learn more about how CAR-T works and what changes happen in the body, which may help improve future care.
This study is for people with blood cancers who are treated with CAR-T cell therapy. Researchers will follow participants over time to learn more about how this therapy works in the real world.
This study looks at how people with blood cancers do after they receive CAR-T therapy, radiation therapy, and/or bispecific therapy. It may help doctors understand which treatment combinations work best and what side effects to expect.
This study looks at how CAR-T therapy affects blood cell counts (cytopenia) in people with multiple myeloma or certain lymphomas/leukemias. You will provide biological samples to help researchers understand these effects.
Hear when a new Patient Reported Outcome (PRO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.